Investigation Overview
May 21, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) was announced concerning whether certain Ligand Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements. The investigation by a law firm concerns whether certain Ligan...
You must register (for free) or login to view the entire investigation.